Literature DB >> 15057548

Audit of a shared-care program for persons with diabetes: baseline and 3 annual follow-ups.

A V Ciardullo1, M M Daghio, M Brunetti, M Bevini, G Daya, G Feltri, D Novi, C A Goldoni, A Guerzoni, A Messori, N Magrini.   

Abstract

In Italy, data on shared-care programs for diabetes are lacking. We described the characteristics of type 2 diabetic population assisted in general practice and evaluated 3 years of follow-up outcomes and performance indicators in a shared-care program in Modena, Italy (1998-2001); only well-controlled diabetic patients were considered. Forty-nine percent of territorial GPs adhered to the project (257 out of 521) and 77% of them sent 6409 paired baseline and follow-up datasheets. Altogether, 97.8% patients had type 2 diabetes, mean age 68.6+/-11.7 years, disease duration 9.6+/-7.5 years, BMI 28.6+/-4.8 kg/m2, HbA(1c) 7.6%+/-1.6%, 16.1% of them were disabled. Among the non-disabled patients, 23.6% had optimal glycemic control (HbA(1c) < or =6.5%); at baseline the prevalence of micro- and macrovascular diabetic complications was: 8.2% microalbuminuria and 2.4% macroalbuminuria plus nephropathy, 11.0% nonproliferative and 3.0% preproliferative retinopathy, 7.0% neuropathy, 1.8% diabetic foot; 8.5% angina, 6.9% TIA or stroke, 6.3% infarction, 5.2% intermittent claudication, 4.1% heart failure. Among the disabled patients 27.9% had optimal glycemic control, but they had more diabetic complications. The performance indicators significantly improved over the 3-year study period: glycemic control indicators increased from 66%-75% to 83%-90% and micro- and macrovascular indicators from 59%-65% to 75%-81%. The outcome indicators also improved: mean HbA(1c) value changed from 7.6%+/-1.6% to 7.3%+/-1.3% and the percentage of people with HbA(1c)< or =6.5% significantly improved over time. Similar trends were observed in both disabled and non-disabled diabetic patients.

Entities:  

Mesh:

Year:  2004        PMID: 15057548     DOI: 10.1007/s00592-004-0137-z

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  5 in total

1.  Effect of combined hormonal and insulin therapy on the steroid hormone receptors and growth factors signalling in diabetic mice prostate.

Authors:  Wagner J Fávaro; Valéria H A Cagnon
Journal:  Int J Exp Pathol       Date:  2010-10-05       Impact factor: 1.925

2.  Dystroglycan patterns on the prostate of non-obese diabetic mice submitted to glycaemic control.

Authors:  Valéria Helena Alves Cagnon; Valéria Helena Alves Cagnon Quitete; Wagner José Fávaro
Journal:  Int J Exp Pathol       Date:  2009-04       Impact factor: 1.925

3.  Primary and tertiary health professionals' views on the health-care of patients with co-morbid diabetes and chronic kidney disease - a qualitative study.

Authors:  Clement Lo; Dragan Ilic; Helena Teede; Greg Fulcher; Martin Gallagher; Peter G Kerr; Kerry Murphy; Kevan Polkinghorne; Grant Russell; Timothy Usherwood; Rowan Walker; Sophia Zoungas
Journal:  BMC Nephrol       Date:  2016-05-18       Impact factor: 2.388

4.  The Perspectives of Patients on Health-Care for Co-Morbid Diabetes and Chronic Kidney Disease: A Qualitative Study.

Authors:  Clement Lo; Dragan Ilic; Helena Teede; Alan Cass; Greg Fulcher; Martin Gallagher; Greg Johnson; Peter G Kerr; Tim Mathew; Kerry Murphy; Kevan Polkinghorne; Rowan Walker; Sophia Zoungas
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

5.  Ginger Ingredients Alleviate Diabetic Prostatic Complications: Effect on Oxidative Stress and Fibrosis.

Authors:  Basma G Eid; Hala Mosli; Atif Hasan; Hany M El-Bassossy
Journal:  Evid Based Complement Alternat Med       Date:  2017-08-17       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.